Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon gamma receptor agonist PubMed FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteopetrosis 4 D010022 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Candidemia 3 D058387 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Pulmonary Fibrosis 3 D011658 ClinicalTrials
Lymphoma 3 D008223 ClinicalTrials
Idiopathic Pulmonary Fibrosis 3 D054990 ClinicalTrials
Arthritis, Reactive 2 D016918 ClinicalTrials
Mycosis Fungoides 2 D009182 ClinicalTrials
Leukocyte-Adhesion Deficiency Syndrome 2 D018370 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Fallopian Tube Neoplasms 2 D005185 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Liver Cirrhosis 2 D008103 ClinicalTrials
Hepatitis C, Chronic 2 D019698 ClinicalTrials
Bronchiolitis Obliterans 2 D001989 ClinicalTrials
Meningitis, Cryptococcal 2 D016919 ClinicalTrials
Mycobacterium avium-intracellulare Infection 2 D015270 ClinicalTrials
Mycobacterium Infections 2 D009164 ClinicalTrials
Peritoneal Neoplasms 2 D010534 ClinicalTrials
Friedreich Ataxia 2 D005621 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Neuroblastoma 1 D009447 ClinicalTrials
Rhabdomyosarcoma 1 D012208 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials
Osteosarcoma 1 D012516 ClinicalTrials
Leukemia 1 D007938 ClinicalTrials
Uveitis, Anterior 1 D014606 ClinicalTrials
Xerostomia 1 D014987 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Retinal Degeneration 1 D012162 ClinicalTrials
Uveitis 1 D014605 ClinicalTrials
Cystic Fibrosis 1 D003550 ClinicalTrials
Sarcoma, Ewing 1 D012512 ClinicalTrials
Psoriasis 0 D011565 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
20.87
Infections and infestations
13.54
Injury, poisoning and procedural complications
12.53
Respiratory, thoracic and mediastinal disorders
9.26
Skin and subcutaneous tissue disorders
5.5
Gastrointestinal disorders
5.37
Nervous system disorders
4.8
Surgical and medical procedures
4.8
Musculoskeletal and connective tissue disorders
4.1
Investigations
3.23
Vascular disorders
2.36
Blood and lymphatic system disorders
2.31
Psychiatric disorders
2.27

Cross References

Resources Reference
CAS NUMBER 98059-61-1
ChEMBL CHEMBL1201564
FDA SRS 21K6M2I7AG